Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 6 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Yesterday
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
2 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Future directions of urinary incontinence research

15 Jul 2017
In 2014, China spent 1,331 billion RMB on R&D, second only to the United States.

Future research on urinary incontinence (UI) should focus on better phenotyping, early disease, risk factor identification, patient-centred research, incorporation of new technologies and prevention, suggests a recent study.

The National Institute of Diabetes and Digestive and Kidney Diseases in the US convened the Summit on Urinary Incontinence Clinical Research in Women in 2014. Participants coming from a broad range of clinical expertise reviewed findings from UI-related studies sponsored by the National Institutes of Health.

They also reviewed results from community-based epidemiological studies such as the Boston Area Community Health (BACH) Survey and from randomized clinical trials such as Program to Reduce Incontinence by Diet and Exercise (PRIDE), and studies conducted by the Pelvic Floor Disorders Network and the Urinary Incontinence Treatment Network.

The BACH Survey results provided fresh insights on precursors, incidence, prevalence and natural history of UI in a diverse group of women.

The Pelvic Floor Disorders Network study, on the other hand, found that anticholinergic medications and onabotulinumtoxinA are effective treatments for urge UI. In addition, Burch colposuspension and retropubic mid urethral polypropylene slings reduce stress UI following pelvic organ prolapse surgery in women with potential stress UI.

The Urinary Incontinence Treatment Network study observed that fascial slings outclass colposuspension, and that retropubic is on a par with transobturator mid urethral polypropylene sling for stress UI.

A preoperative urodynamic study was found to be noninferior to basic office examinations for surgical outcome in patients with stress UI. Female patients were not allowed to discontinue antimuscarinics for urge UI with the addition of behavioural intervention.

Finally, PRIDE indicated that losing weight could significantly reduce UI.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 3 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 6 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Yesterday
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
2 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.